Connaughton Bernadette
Reporting owner on Forms 3, 4 and 5, CIK 1662521.
Connaughton Bernadette reported on 1 issuer in 1 filing, the latest a Form 4/A filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| HALO · HALOZYME THERAPEUTICS, INC.CIK 1159036 | director | 1 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-05-05 | A granted | +3,796 | $0 | 42,294 | Form 4/A |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4/A 0001159036-26-000139 | HALOZYME THERAPEUTICS, INC. | 2026-10-08 |